Shopping Cart
- Remove All
Your shopping cart is currently empty
Moxilubant HCl is a small molecule leukotriene B4 receptor 1 (LTB4R) antagonist for the treatment of immune system disorders, skin and musculoskeletal disorders, and may be used in studies of psoriasis and rheumatoid arthritis.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $82 | In Stock | |
| 5 mg | $181 | In Stock | |
| 10 mg | $267 | In Stock | |
| 25 mg | $413 | In Stock | |
| 50 mg | $592 | In Stock | |
| 100 mg | $819 | In Stock | |
| 200 mg | $1,090 | In Stock |
| Description | Moxilubant HCl is a small molecule leukotriene B4 receptor 1 (LTB4R) antagonist for the treatment of immune system disorders, skin and musculoskeletal disorders, and may be used in studies of psoriasis and rheumatoid arthritis. |
| In vitro | Moxilubant hcl inhibits LTB4 signaling with a potency of 2–4 nM. |
| In vivo | Moxilubant hcl (100 to 500 mg; oral; once or twice daily for 7 days) inhibition LTB4 pathway reached at least 75% (150 mg) and pathway inhibition reached 100% (300 mg).[1] |
| Synonyms | Moxilubant hcl(146978-48-5 Free base) |
| Molecular Weight | 492.05 |
| Formula | C26H38ClN3O4 |
| Cas No. | 146957-32-6 |
| Smiles | Cl.O=C(C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(=N)N)C(OC)=C1)N(C(C)C)C(C)C |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (101.62 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.